Greetings and welcome to the Maximus Fiscal 2024 Fourth Quarter and Year-End Earnings Conference call. At this time, all participants are on a listen-only mode. A brief question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jessica Batt, Vice President of Investor Relations and ESG for Maximus. Thank you, Ms. Batt. You please go ahead. Good morning and thanks for joining us. With me today is Bruce Caswell, President and CEO, David Mutryn, CFO, and James Francis, Vice President of Investor Relations. I'd like to remind everyone that a number of statements being made today will be forward-looking in nature. Please remember that such statements are only predictions. Actual events and results may differ materially as a result of risks we face, including those discussed in Item 1A of our most recent Forms 10-Q and 10-K. We encourage you to review the information contained in our recent filings with the SEC and our earnings press release. The company does not assume any obligation to revise or update these forward-looking statements to reflect subsequent events or circumstances, except as required by law. Today's presentation also contains non-GAAP financial information. Management uses this information internally to analyze results and believes it may be informative to investors in identifying trends, gauging the quality of our financial performance, and providing meaningful period-to-period comparisons. For a reconciliation of the non-GAAP measures presented, please see the company's most recent Forms 10-Q and 10-K. And with that, I'll hand the call over to Bruce. Thanks, Jessica, and good morning. With preparation for the incoming administration now underway, I would like to offer perspective on how Maximus is favorably positioned for opportunity, as well as areas we're watching with interest. As we've experienced through prior transitions in administrations, we are naturally at a point where there are more questions than answers, leading to speculation and uncertainty on topics from federal budget priorities to the likely role and impact of the proposed Department of Government Efficiency. Our business has successfully operated for nearly half a century as a proven partner to governments across numerous political transitions, affecting both the executive and legislative branches at the federal and state level. Over the course of these transitions, we've developed the capacity to support our customers implementing various policy priorities, from expanding social safety net programs to providing states greater flexibility in program delivery. Over the decades, the administrations we've served have seen the value in leveraging private sector partners like Maximus to provide high-quality, scalable, and cost-effective citizen services, and to enable agencies to deliver on their mission through technology modernization. Our position as the largest partner to government in the administration of well-established entitlement and related mandatory spending programs has enabled us to deliver strong financial results with positive long-term trend lines spanning many administrations. Some of the largest mandatory spending programs we support, such as compensation and pension benefits for veterans, are perennially supported on a bipartisan basis. When we set our last strategic vision for the company, there was a deliberate focus on bipartisan priorities that are fundamental to the government's role supporting its citizens. For example, with considerable government business still transacted on paper, the need for citizen services digitally enabled is undisputed. To date, only 2% of federal government forms have been digitized. Notably, the Digital Experience Law, signed under the first Trump administration, progressed to implementation guidance under the Biden administration. The priority of supporting our veterans with medical disability examinations through the compensation and pension claim process expanded under the PACT Act, with bipartisan support that continues. States seeking to more effectively manage Medicaid budgets have and are likely to continue to rely on partners like Maximus to provide independent and conflict-free assessments for beneficiaries enrolling in long-term services and supports. Technology modernization remains a long-term spending priority for civilian, defense, and health agencies, not only for the productivity efficiencies it can deliver, but as a strategic imperative in response to an ever more complex cybersecurity and geopolitical landscape that exposes the weaknesses of antiquated systems and processes. Looking ahead, the fundamental obligations of government to support its citizens will not change, but it's prudent to consider how the means by which programs are delivered may continue to evolve. For example, through pandemic-era legislation, the prior Trump administration granted states greater flexibility to work with private sector partners in the administration of certain benefit programs. Whether accomplished through legislation, executive order, waiver authority, or rulemaking, Maximus has decades of experience guiding our customers through changes that can impact eligible populations and program delivery models. Our ability to translate policy priorities into technology-enabled operations, implemented and scaled with agility, and designed to deliver quality services and value for money, remains a hallmark of our business. Our role administering programs that support more than 100 million Americans, including veterans, senior citizens, student loan borrowers, and individuals with disabilities, positions us uniquely to identify opportunities with our customers and the incoming administration to advance the bipartisan goals of improved customer service and effective program delivery to eligible populations. So while this interim period of transition has naturally created uncertainty, what we do know is that Maximus is an established, reliable, and trusted partner to governments on both sides of the aisle. We are well prepared to advise, adapt, and implement any changes that may affect our current programs and, perhaps more importantly, to partner in the effective implementation of new priorities as they become known. Just a year ago, I similarly talked about this being an unprecedented era, using words like volatility and ambiguity to describe the global environment we anticipated for fiscal year 2024. At that time, despite the global uncertainties, we were confident in our ability to return to stability and more normalized operations. As David will share, our teams exceeded our forecasts through solid execution across the segments while benefiting from strong volumes in certain programs. We continue to deliver on our three-to-five-year strategy and meet or exceed our targets. Highlights from FY 2024 include organic revenue growth of 9% and record adjusted earnings per share of $6.11 per share. Our team's dedication to and focus on our strategic goals have been instrumental in these achievements. Throughout FY 2024, we prioritized both top-line growth, refining our approach to new work and project expansion, and bottom-line efficiency through various cost reduction and optimization initiatives. We plan to continue these priorities this fiscal year as our investments in business development, innovation, enterprise technology, and performance management drive pipeline conversion and greater operating leverage to set up FY 2026 and beyond. While David will share our formal guidance for FY 2025, I'm particularly proud that we're forecasting to achieve a 5% revenue compound annual growth rate over a three-year period, consistent with our goal of mid-single-digit organic growth. With that, let's look at some of our recent wins that will contribute to top-line growth. In FY 2024, we successfully secured two task orders under the IRS Enterprise Development Operations Services, or EDOS, blanket purchase agreement. Combined, the task orders contribute total contract value of $128 million and represent two of the six task orders awarded to date. These victories are key milestones in our strategic focus on technology modernization and underscore our role with the IRS as one of their trusted partners. Within our federal segment, we recently secured the rebid of our California Independent Medical Review project, valued at $120 million total contract value over a base three-year period. Since 2013, we've supported the Department of Industrial Relations' Division of Workers' Compensation by providing independent medical reviews. This program serves as a cornerstone for our Future of Health strategic pillar and showcases the long-term customer relationships that are a key element of our business model. We are thrilled to share that Maximus has secured a recent victory collaborating with an agency within the Department of Defense to enhance its artificial intelligence capabilities. This initial contract, along with the expected follow-on contract, is particularly notable as it introduces us to a new client and reflects a new contracting model for Maximus that enables customer-driven R&D. In a crowded market with many companies offering strategic advisory services on AI, we believe our selection acknowledges the practical capabilities that we've built and the credibility of our subject matter experts in this area. We look forward to supporting this DOD customer in their AI roadmap and to expanding these services to other defense and civilian agencies. Our latest victories not only showcase our ongoing success in executing on the pillars of our three-to-five-year strategy, but also highlight our capability to enter new agencies and expand into related markets. Turning to the bottom line, I'm excited to share an update on our Maximus Forward program. In FY 2024, our enterprise technology organization undertook significant change. We welcomed Derek Pledger as our Chief Digital and Information Officer, or CDIO, and with him, Mike Raker, as our Chief Technology Officer. Under their leadership, the Office of the CDIO has sharpened service delivery and execution, deepened our capacity to identify, shape, and respond to customer needs, and positioned Maximus to drive greater innovation in our operations and solution offerings. Three highlights that illustrate these accomplishments include: first, working with our federal market leads, our CDIO team has mapped more than 90% of the known requirements in our near-term pipeline to our capability sets, which we call mission threads. We've concurrently identified certain accelerators, like AI/ML, that we believe will further differentiate our ability to deliver on mission threads and contribute to improved win rates. Second, through Maximus Forward, enterprise technology has contributed significant annual recurring savings and efficiencies, some of which have been reinvested. Finally, in FY 2024, we launched our Global Capability Center, or GCC, through a small acquisition of a long-time delivery partner. Our GCC is now part of how we solution, deliver, and innovate as a company. We view Maximus Forward as an ongoing transformation initiative driven out of my office that will continue to have us challenge established structures and processes, promote more efficient operations, and provide for reinvestment in the business to address priorities from talent acquisition and development to technology and innovation. Let me turn now to our award metrics and pipeline. For fiscal year 2024, signed awards totaled $2.2 billion of total contract value. Further, at September 30th, there were $312 million worth of contracts that had been awarded but not yet signed. These awards translate into a book-to-bill of approximately 0.4 times for the trailing 12-month period. As we mentioned last quarter, the lower book-to-bill reflects a lower-than-normal period of rebid activity, and we anticipated that it would remain below one through the end of the fiscal year. For context, about half of our awards were new work, so only 0.2 times came from rebids, despite a historically consistent rebid win rate of about 90%. If rebids were evenly distributed, a typical year would have nearly 1.0 times coming from rebids alone. As the volume of adjudications for both rebids and new work are expected to increase over the next 12 months and return to a more normal volume, given the circumstances as we know them today, we anticipate that our book-to-bill will return to 1.0. Our pipeline at September 30th was $54.3 billion compared to $44.1 billion reported in the third quarter of fiscal 2024. The September 30th pipeline is comprised of approximately $4.2 billion in proposals pending, $7.1 billion in proposals in preparation, and $42.9 billion in opportunities tracking. Of our total pipeline of sales opportunities, approximately 48% represents new work. Additionally, 68% of the $54.3 billion total pipeline is attributable to our U.S. Federal Services segment. As a reminder, the increased pipeline is largely driven by the CMS Contact Center Operations, or CCO, contract valued at $6.6 billion. Our commitment to challenging the basis for and legality of the CCO solicitation remains unchanged. Last month, after receiving a partially sustained ruling from our GAO protest, we filed suit in the U.S. Court of Federal Claims, or COFC. Concurrently, we sought and received a stay of award from the government until March 15th, 2025, to facilitate judicial review and allow the court to render its decision before that date. While the COFC case is pending, we acknowledge the recently announced planned changes in key roles within the administration. We remain steadfast in our view that the Labor Harmony Agreement requirements in the solicitation are unnecessary, inappropriate, and illegal. As a reminder, the justification provided for the rebid was the potential risk of a service interruption due to labor actions and inadequate continuity of operations plans. I'll note that recently, our ability to maintain operations without disruption was soundly demonstrated when successive hurricanes devastated much of the Southeast. Many employees in the region faced challenges, and Maximus responded by safeguarding their pay while temporarily suspending operations directly in the storm's paths. With certain contact centers closed to protect our employees and their families, their colleagues across the country stepped up to the challenge, many working unscheduled overtime. Service remained uninterrupted, with the CCO team handling over 190,000 calls without any impact on call wait times. Finally, also included in our pipeline are both the two-year rebid of most regions under the VA medical disability exams, or MDE, contracts, as well as the expected procurement for the successor contracts for all regions of this work. The VA recently executed the next option year for our current contracts for all regions, and we expect to receive results of the two-year rebid before calendar year-end. As we enter a new fiscal year, I remain confident in our position and optimistic about the growth of the company. We've spent much of the last few years focusing on our strategic plan, working to ensure we have the right resources in place and making investments in technologies and capabilities that help to ensure we are well positioned not only to protect our base but win new work for current and new customers. We're quickly approaching the primary milestone of our three-to-five-year strategic plan and have several quarters behind us where we've demonstrated our ability to deliver on the targets we set out. I'm very proud of the team at Maximus for their passion, focus, and exceptional work in driving our strategy forward. Thanks to their commitment, we're firmly on track to building a successful and dynamic Maximus for the future. And with that, I'll turn the call over to David. Thanks, Bruce, and good morning. I'll take a moment to expand on the recap of fiscal year 2024, which I'm particularly proud of as we delivered on our commitments and had impressive performance across our portfolio of contracts. This time last year, we expressed optimism from healthy tailwinds that could drive a strong year. Looking back, we exceeded those high expectations as we supported our government customers on important complex programs, some of which experienced unprecedented volumes across the year. Our landing spot for the year was organic revenue growth of 8.8% and adjusted earnings of $6.11 per share, just above the midpoint of the forecasted earnings range from the last call. A hallmark of our business model is cash flow generation, and this year delivered free cash flow just over $400 million. That's nearly 80% growth over the prior year and represents a 1.3 times conversion to net income, which is exactly where we want the business to be. Meanwhile, we stayed on course with capital allocation priorities and maintained a disciplined approach with debt paydown. We finished this year at 1.4 times net leverage, which is almost a full turn of leverage reduction in a one-year period. The final item I'll highlight is that our official guidance for fiscal 2025 aligns with the early color we provided in August. The midpoint of $5.35 billion of revenue and $5.85 of Adjusted EPS reflects underlying growth when you account for the excess volumes that we captured in fiscal year 2024. More on that later. Let's go to total company results. For the full fiscal year 2024, consolidated revenue increased 8.2% to $5.31 billion. As I mentioned, organic revenue growth was 8.8%, comfortably exceeding our longer-term target of sustainable mid-single-digit organic growth. The three primary pieces of growth were: one, core programs with volume growth that we believe have durability for the foreseeable future, two, programs tied to Medicaid-related activities, such as redeterminations that have experienced a return to full volumes, and three, incremental work on those Medicaid-related activities that provided surplus volumes in earlier periods and were concluded by the fourth quarter. I'll touch on the last piece more in our fiscal 2025 guidance discussion. On the bottom line, fiscal year 2024 Adjusted EPS was $6.11 per share, which is a significant step up from the $3.83 per share for the prior year. The same pieces of growth I just mentioned contributed to this year's earnings power. Also, as a reminder, we had a cybersecurity incident in fiscal 2023 that had a $0.35 per share impact. Let me provide more commentary on margins. First, as we cross fiscal years, we are altering the profitability metric we use for guidance, moving from adjusted OI dollars to adjusted EBITDA margin. This change is responsive to investor feedback as adjusted EBITDA aligns better with disclosures from our government services peers, thus providing investors a more relevant comparable metric. Our adjusted EBITDA definition is detailed in the earnings presentation, and in short, the only adjustment is to exclude divestiture-related charges. For the full fiscal 2024, our adjusted EBITDA margin was 11.6% and compares to 9.1% for the prior year. On the last call, we said the adjusted OI expectation was an approximately 11% margin. That translates to an expectation of an 11.6% adjusted EBITDA margin, which we delivered. A quick word on total company performance for the fourth quarter before I turn to segments. Fourth quarter of fiscal 2024 revenue grew 4.4%, or 4.7% on an organic basis. Adjusted EBITDA margin was 11.0%, and adjusted EPS was $1.46 per share in the quarter. We believe that the fourth quarter is a good indicator of the underlying earnings power of the business on a go-forward basis, as it excludes the excess volumes that benefited prior quarters. Turning to the U.S. Federal Services segment, revenue increased 13.9% to $2.74 billion. All growth was organic and driven predominantly by volume growth on expanded clinical programs. The operating income margin for U.S. Federal Services was 12.2% in fiscal 2024, as compared to 10.4% in the prior year. A higher mix of performance-based work, which includes assessment volumes, continued to be a driver of margin enhancement in the segment. For the U.S. Services segment, revenue increased 5.5% to $1.91 billion. All growth was organic and driven by strong performance across the core Medicaid-related portfolio that has returned to normal levels, plus extra volumes that contributed to some overperformance in the segment. This manifested in the first through third quarters of fiscal 2024 and was concluded by the fourth quarter. The U.S. Services operating income margin was 12.9%, as compared to 10.1% in the prior year. The overperformance I just mentioned also enhanced margins in the segment. The margin in the fourth quarter was a healthy 11.1%, which we believe is more indicative of future periods' performance for the segment. Outside the U.S. segment, revenue decreased 4.6% to $657 million. Divestitures that occurred in the prior year reduced revenue for the year by 6.1%, while currency effects provided a partially offsetting benefit of 1.7%. It's worth noting that in the second half of the fiscal year, organic growth accelerated in the segment and was attributable to program growth primarily in the United Kingdom. The segment realized operating income of $8 million for fiscal 2024, compared to an operating loss of $9 million in the prior year. Our forecast going into this year was slightly above breakeven, and the fact that we landed right in that window demonstrates our efforts to improve profitability and contain volatility in the segment are taking hold. The fourth quarter delivered a 4.8% margin, showing improvement across the year and attributable to strength in core programs that remain in the segment. That said, and as we've alluded to on prior calls, we are focused on executing a key portfolio-shaping action that should reliably move the segment into the 3%-7% margin range and ultimately closer to the profitability of the domestic segments. Once completed, there should be a modestly smaller footprint that emphasizes the profitable components. We have studied the segment carefully and see a healthy pipeline of exciting opportunities squarely aligned with the company's strategic vision. Successful capture of those opportunities should lead to ongoing diversification of customers, increased scale, and greater mix of higher-value services. Let's turn to the balance sheet and cash flow items. As of September 30th, 2024, we had gross debt of $1.15 billion, and we had unrestricted cash and cash equivalents of $183 million. We finished this year with a debt ratio of 1.4 times, down from 2.2 times at this point last year. As a reminder, this ratio is our debt net of allowed cash to consolidated EBITDA for the last 12 months, as calculated in accordance with our credit agreement. We paid down a little over $100 million across this year, and the remaining improvement to the leverage ratio was from an increased trailing 12-month consolidated EBITDA. Cash flows from operating activities totaled $515 million, and free cash flow was $401 million. This compares to $314 million and $224 million, respectively, for the prior year. Through good collections, our Days Sales Outstanding, or DSO, have remained consistent at 61 days at September 30, 2024, and 60 days at the same point last year. During fiscal year 2024, we repurchased approximately 0.9 million shares, totaling about $73 million. Subsequent to year-end, between October 1st and November 19th, we repurchased an additional 0.5 million shares for approximately $43 million. Accounting for the activity through November 19th, we have approximately $128 million remaining on the $200 million authorization granted by the Board of Directors in June. I'll briefly touch on our priorities for capital allocation, which remain essentially unchanged from our disciplined approach. We first fund organic investments, which are typically a combination of capital expenditures and expenses and do not require substantial outlays. Next, we maintain a quarterly dividend that we intend to grow over time with earnings and that currently stands at $0.30 per share. After these, our priority for capital deployment is strategic acquisitions intended to accelerate organic growth. We presently have an appetite for M&A that brings us new or enhanced capabilities or a new or expanded customer set. As always, we will evaluate acquisition opportunities with discipline, and our balance sheet provides capacity for good opportunities in fiscal year 2025 and beyond. Lastly, we repurchase our shares opportunistically, depending on current market conditions. In recent periods, debt paydown took more of a commanding focus, and now we are well below our two to three times target range. Absent significant M&A, an ongoing reduction to the leverage ratio should be expected going forward, albeit at a slower pace than recent periods. Let's go to fiscal 2025 official guidance, which is consistent with our early color provided on the last call. For fiscal 2025, revenue is projected to be between $5.275 billion and $5.425 billion. Adjusted EBITDA margin is estimated to be approximately 11%, and adjusted EPS is projected to be between $5.70 and $6 per share. I'll share some thoughts on guidance. We believe the consolidated business is capable of growing organically in the mid-single digits over the longer term. Bruce mentioned the compound annual growth rate from Fiscal Year 2022 to the midpoint of Fiscal 2025 guidance is 5.0%. The added benefit to that measurement is that it naturally ignores the excess volumes in Fiscal 2024. It is also despite the fact that we have made a number of small divestitures over the period, so the organic growth over that horizon is even higher. I'd like to note that we estimate that this year's guidance has modest underlying organic growth. As I mentioned, we saw excess volumes primarily in U.S. Services that led to successive guidance raises across Fiscal 2024, and which will not recur in Fiscal 2025. Guidance for Fiscal 2025 implies that we are able to backfill that piece with organic growth stemming from both the U.S. andOutside the U.S. segments. It is worth pointing out that, since the early color we gave in August, our forecasted revenue from backlog has increased. However, given the risk of procurement delays relating to the transition of the new administration, we have been prudent in de-risking our revenue guidance, which now includes only about 2% of revenue from new work not yet won. Typically, that figure would be 5% or a bit more. This small amount of new work that we have included assumes partial contributions in fiscal 2025, but would drive more significant contributions to fiscal 2026 and beyond. For the two outstanding rebids that Bruce mentioned, a reminder that the CMS CCO contract is under an option period through September 2025, and that the desired early recompete, regardless of outcome, should not have an impact to fiscal year 2025. For the Veterans Affairs MDE two-year recompete for purposes of raising the volume ceiling, we've anticipated a seamless transition to the new contract and maintaining status quo as a leading provider. Let me provide some color on full-year segment margins. We expect the U.S. Federal Services margin to be nearing the 12% range, which is broadly in line with fiscal 2024 performance. We expect our U.S. Services segment margin to be in the 11% range, and which is aligned with fourth quarter exit rate when the segment's overperformance had Outside the U.S., we estimate a margin between 1% and 3%, representing incremental forward progress on the segment's profitability. Further improvement through action remains a priority in the near term. From a cash flow standpoint, we expect free cash flow between $345 million and $375 million for fiscal 2025. Consistent with prior years, we expect a slightly negative free cash flow in Q1 as a result of seasonality and timing of certain payments. Our CapEx spend rate should also slow for fiscal 2025 compared to the prior year and trend more towards 1.5% of revenue. Some other assumptions around fiscal year 2025 include an estimated $92 million of intangible amortization expense and $45 million of depreciation and amortization tied to PP&E and capitalized software. Interest expense is estimated to be about $65 million. Finally, the full-year effective income tax rate should be around 25%, and weighted average shares should be about 61 million. Looking further ahead and following the transition to Adjusted EBITDA guidance, we wanted to provide a current view on our near-term margin expectations. We believe a reasonable range in the near term is 10%-13% Adjusted EBITDA margin. With our guidance for fiscal year 2025 of approximately 11%, this range demonstrates our view that there are further opportunities for margin enhancement in the years following fiscal 2025. We also have some contingency built into the low end of the range to account for uncertainty that is inherent in looking further into the future. I'll wrap up by expressing the same optimism for fiscal 2025 as we had at this point last year. We're starting another year with strong visibility to our portfolio of programs and ongoing attention towards cost management and operational excellence. And with that, we'll open the line for Q&A. Operator? Thank you. The floor is now open for questions. If you would like to ask a question, please press star one on your telephone keypad at this time. A confirmation tone will indicate your line is in the question queue. You may press star two if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up the handset. Today's first question is coming from Charlie Strauzer of CJS Securities. Please go ahead. Thank you. Good morning. Sorry about that. Good morning, Charlie. Very well. Hope you're well, too. Good. Thank you. Bruce, maybe we could talk a little bit more about the CCO contract, just to kind of get that out of the way. Maybe a bit more of a refresh there as to anything moving beyond what we've already seen. Sure. Well, let's see. As I mentioned in my prepared remarks, our protest at the GAO level was upheld on one component, which was that the procurement needed to be clarified. And the clarifications that were issued to the procurement also updated the submission deadline for the phase two proposals, also the intended notification of award date. So phase two proposals are still due before the end of November, and the current administration indicated that they would not make an award announcement until March of 2025. Obviously, things have changed since then. We are under an option year that's been exercised that funds us entirely through this current fiscal year. And as I mentioned, there's a lot to watch presently in terms of the new positions that are being announced, some as recently as just the last couple of days. So while there'll very likely be changes in priorities in the new administration at HHS, we're only recently learning about these new leadership positions and discerning, I think, with everybody else what that might mean. So coming back to the basics, we've continued to maintain, and as I mentioned in my remarks, that we're very steadfast in our view on the lack of the need for a Labor Harmony Agreement and therefore the procurement itself. We're, like I said, operating under the third option period of the existing contract. So were that to continue, there are six additional option years that are left on that contract that could be exercised. I'd probably further note that under the prior Trump administration, they were very supportive of our program delivery model, the excellent independently measured performance that we were able to deliver. And it's worth also noting that together we were able to navigate, obviously, the significant Continuity of Operations challenge that was required to accommodate the pandemic. And that was probably the greatest, most extreme test of Continuity of Operations. As I said in my prepared remarks, it's that fundamental basis of whether Continuity of Operations is adequate to sustain conditions like that and others, including labor actions, that has led the current administration to want to include a Labor Harmony Agreement. So we feel like we've more than demonstrated the efficacy of that model. So to summarize, we're focused on continuing to provide excellent service to 65 million Americans, and we're going to vigorously pursue our claim in the U.S. Court of Federal Claims, and we'll support the new administration in their leadership transition as we have prior administrations. So that's where things stand, Charlie. Great. That's a good segue. Looking at Trump 1.0 versus Trump 2.0, maybe you could provide a little bit more color on how the company fared outside of the CCO under the last Trump administration. How should we think about Trump 2.0 in comparison to the prior administration? Yeah. I think that's the question that everybody in the govcon sector is getting these days. Let me give you our perspective on it. A number of points of which, quite frankly, I'll pick up from the prepared remarks in terms of the nature of the programs that we administer, the nature of our business model being focused on efficient delivery of government services. Let me kind of back up to Trump 1.0. During Trump 1.0, there were delays in the appointments of individuals into key positions to make decisions on procurement. As you'll recall, that slowed the procurement process down longer than it had historically taken during administration transitions. I would say that we don't expect that to be something that would repeat this time. This administration has a lot of experience. They've had a lot of time to put plans in place and get people into key positions. And I think we're seeing a lot of that already in terms of the tempo of the announcements that have been made. So less likely in the second Trump administration to see those delays. However, in any administration change, inevitably, certain procurements get slowed down. And whether you think about those in terms of are they strategic priorities or not as the administration transitions, or are they just at a dollar value where the level of scrutiny and sign-off that's going to be required then makes it even more dependent on having key positions filled, that's an open question. So we wanted to be prudent in our forecasting for FY25. And David can comment more on this as we get into more questions. And that's why only 2% of our revenue for FY25 really would come from new work that we would be winning and delivering in this fiscal year, which would compare maybe to 5% in a normal year. So we've tried to incorporate that. Another comment I would make is that during the last Trump administration, that administration was very much open to ideas that we and others, but I will give our team a great deal of credit, brought to the table related to granting states greater flexibility to use private sector contractors to administer certain programs. And that flexibility to contract that we've talked about on prior calls and during that period was ultimately baked into some legislation during the pandemic. And it was very prescient to do that because that created the opportunity for governors to turn to private partners when we were in a crisis, and particularly as it related to the administration of unemployment insurance benefits. And if I recall the numbers correctly, there were 37 different states or so. I'm going to say between 34 and 37 that turned to private partners to help with that crisis. And Maximus ended up serving actually a majority of those states. So that was great. The pie was expanded for everyone, and we felt that we were able to demonstrate our value to many of our state clients. So point two would be, I think, as we transition to Trump 2.0, if we look at the past as prologue, being a company that's well-positioned at the state level as well as at the federal level is a strength for our business, and we feel like we're such a company. The last point I would make there is that compared to Trump 1.0, we're a very different company than we were then. We accomplished some very significant acquisitions in the 2021 time period, as you're very well aware. And so we've got a much broader portfolio of offerings. We've got a much more significant business development and market leadership team in our federal business than we had historically. And we have been successful now in winning new work in agencies like the Department of Homeland Security. I even mentioned the AI work that we've just recently won in one of the units of the Department of Defense. So we're in a position where we can have conversations during this administration that we might not have had historically. So with that, I would just say, turning for a moment to the Department of Government Efficiency. I think we're all wondering and watching closely in terms of what that will mean, how that will work procedurally in terms of what levers are available to them, how they will work with Congress in terms of executing priorities. And rather than speculating at an agency level or in terms of broad swaths of spending or what the implications might be, I would say we're taking a very balanced view. One of the risks that we need to keep in mind is if there were to be a reduction in the number of civil servants in government, what impact would that have in the contracting and procurement functions? And could that in some way just, and there's already been a silver tsunami that we've talked about on prior calls of individuals retiring from government. So you have to be prudent and ask yourself the question as a government contractor, what could the implications be in terms of just the workforce that's needed to execute the contracts, administer, and oversee the contracts in that environment? And then the next question would be, what will the priorities be of an organization like that? Well, in our view, we're a company that's really purpose-built to help deliver efficient government services in a model that is focused on high quality and accountability. And we've done that for decades, and we feel like we have a great track record. I think, apparently, I would say a fairly unique combination of a track record and experience with these types of performance-based contracting models and programs that are a combination of people, process, and technology that can be deployed to efficiently deliver the mission of government. And also decades of experience and perspective where we can bring our knowledge on what works and doesn't work to conversations with individuals who might be in new roles in departments where they lack necessarily the institutional knowledge and familiarity with how those departments function and have delivered their programs historically. So for now, we're just going to make sure that we are able to share our thoughts and our subject matter expertise and be in the conversations where we need to be. But even before that, I guess I would underscore, we're going to focus on continued high-quality execution and service delivery to more than 100 million Americans that rely on us every day for critical government programs, many of which, as I mentioned in my prepared remarks, are entitlement by nature and, if not entitlement, mandatory spending programs. So we'll focus on execution, we'll listen to our customers, and we'll support our customers as they go through this transition and be able to certainly offer a number of ideas that we would have on ways to drive even greater efficiency in certain programs. Great. Thanks. I think that's, sorry for the long answer there, Charlie. No, that's terrific, actually. Thank you for providing the extra color there. And maybe shifting to David for a second on the revenue guidance and the margins implied. It looks like revenue guidance is in line with what I was expecting. But margins are slightly below, not terribly, but just kind of some more color as to what's driving that, if you could. Sure. Yeah. So I can't help but first talk about fiscal year 2024 margins, pointing out again that those benefited from those excess volumes in the U.S. Services segment, which were quite accretive. So let me help kind of size what that impact is, which may help your understanding of where we landed for fiscal year 2025. So recall the midpoint of our guidance coming into fiscal year 2024 was $5.20. So we exceeded that by $0.91. And as we said on the last call, a significant portion of that was driven by the temporary excess volumes that we don't expect to recur in our fiscal year 2025 forecast. Another helpful way, I think, about sizing it is on margins. And if you look back a year ago, our guidance going into fiscal year 2024 was for adjusted OI margin of 9.8%. So if you add in our depreciation, which is about 0.6%, that translates into guidance going into the year for adjusted EBITDA margin of 10.4%. So we came in at 11.6%, which demonstrates that the overperformance came in at a higher margin. If you look at Q4, which we say was free of those excess volumes, we were at 11% adjusted EBITDA margin, which is consistent with our fiscal year 2025 guidance. So I think that kind of path from 10.4% to now 11%, you get a sense that a portion of the in-year performance was temporary, but a significant portion is also durable and carries forward into that 11% guide. So kind of said another way, looking at 2025, we're backfilling that higher margin revenue from last year with work that naturally comes in at more normal levels of profitability. Great. And maybe we can segue into the backlog, if we could. Maybe Bruce can maybe provide us some more clarity on the differential versus last year and help us understand more about what needs to happen to improve book-to-bill. Just help us clarify that a little bit more. Great. So, Charlie, I'm going to ask David to start with the mechanics of the big pieces in the backlog, and then I'll provide some more color on the book-to-bill expectations as we go forward. Sure. Yeah. So looking at the backlog, reduction naturally happens when we burn through revenue. If you start with our backlog as of this time last year, remove $5.3 billion of fiscal year 2024 revenue that we booked. Then we partially backfilled that with $2.5 billion of signed and unsigned awards. As Bruce said, fiscal year 2024 had an unusually low level of rebid adjudications, which is not a bad thing. In the case of this year, simply more backlog was burned than replenished through the new contract awards. Of the remaining reduction to backlog, the largest driver were the portion of contracts for the VA Medical Disability Examination contracts that are currently going through a recompete due to the contractual needs. The value attributable to the remaining life of those was removed from our backlog as of September 30. Now that outstanding two-year procurement is sitting in our pipeline, specifically in opportunities pending. Then last, you may ask for CCO. In that case, the remaining option periods of our current contract remain in our reported backlog, which follows our standard practice of including option periods unless we have a high degree of confidence that they would not be exercised. So those are the big moving pieces. Bruce? Yeah. So a little bit more color on the book-to-bill dynamics. So first of all, David's noted, and I noted in my remarks that we had a relatively light year as it related to rebid volume. We expect that to be shifting as we come into 2025. And as you well know, there are some rebids that are out there right now that we anticipate to be awarded in the near term, including the VA MDE contracts, which we would hope to hear on before the end of the calendar year. I am pleased that for the rebids that we did have this last year, we were right in the middle of the fairway in terms of our historical rebid win rates. We've often said that we like to model our business, and we intend our business to demonstrate a 90% plus or minus rebid win rate, and that's been the case over the last five years and continues, which is great. We expect that the book-to-bill, therefore, will trend more toward 1.0 as we get into FY25 and we see a more normal year for rebids, but also some of the procurements that have been in the pipeline and planned, we feel like we've got a very strong pipeline. We've built out and made investments in our market leads teams, the business development teams, the capture teams, and so forth. A number of the procurements that we've been tracking have been progressing according to plan. I would say they are probably less likely to be in a category where they're thought to be discretionary and maybe would be slowed down or different decisions made. These are, again, we like to strategically focus on programs that generally enjoy bipartisan support and are essential government services and so forth. The fact is the fundamental need for government to serve its citizens and to serve them efficiently and in a high-quality fashion hasn't changed. As I also mentioned, the fundamental challenges of government as it relates to aging technology platforms, the need to modernize, the need to accommodate advances in cybersecurity standards and so forth that begin at the DOD level and then will likely flow their way down into the civilian level, that hasn't changed. So we feel like we've got a robust pipeline. There may be some delays, and we've been cautious about that as it relates to the procurement, the pace or velocity of getting procurement decisions through. And I feel like we're in a good position as we prosecute that pipeline in FY25 to build that book-to-bill backup as we turn the corner into 2026 and then beyond. And I'll also mention that we had four consecutive quarters in FY22 and 2023 above 2.0 on book-to-bill. As we saw, that was a period of kind of outsized volume as it relates to rebids. The final point I'd make is that I'm pleased that our federal pipeline, which I noted, I think that's at probably an all-time high in terms of the percentage of our total pipeline that is federal. I noted it at 68%. That comprises a lot of opportunities that are very much aligned with the capabilities that we've acquired over the last couple of years. So the 2021 acquisitions are doing exactly what we intended. And that is when we invest in an acquisition like that, it's to create that next growth platform for the company. And we're seeing a great alignment with opportunities that allow us to build on the capabilities that we have with the VES acquisition, but also with the, I would go back to the Acentia acquisition in 2015 and the Attain Federal acquisition in 2021. So collectively, those service lines are quite substantial. And honestly, a couple of years ago, we wouldn't have had the permission to win and the opportunity to bid on a lot of the pipeline that we're now prosecuting. I'm looking at all those conditions and the investments that we've made, and that collectively makes it clear that we've got plenty of targets to go after. And I feel like we're in a very good position to win our fair share. Great. That's very helpful. Thanks, Bruce. Just shifting back to the guidance, if we could talk about quarterly cadence as we build out our models for fiscal 2025. David, is there anything that we need to build into our thinking from a cadence standpoint? Sure. Nothing too unusual. On the top line, we're fairly evenly distributed across the year, with the exception of seasonality does typically drive higher revenue in Q1, as is normal related to open enrollment activities. On the bottom line, our guidance, as I said, is 11% EBITDA margin for the year. Looking across the year, we expect the first half of the year would be a little bit lower than that, and the back half of the year a little bit higher than that. So taken together, that would show a trend of earnings growing from quarter to quarter over the fiscal year. Got it. And same on the segment basis too. How should we think about that? Yeah. Same on the segment basis. I mean, of the three segments, U.S. services, we pointed out, have the excess volume. So the top line on U.S. services expected to be down a little bit year over year as a result of that, with the other two segments growing year over year. Great. And then lastly, on cash flow, obviously, you had a very strong year this year with just over $400 million of free cash flow. You're calling for a slight dip in that. This year, what are some of the things that are driving that? Sure. So first, looking at fiscal year 2024, just dissecting the performance, net income, DSOs, CapEx, were all pretty much in line with our expectations. So it was really other components of working capital that contributed to the overperformance, which you can see if you look at our cash flow statement as a component. It's a lot of positive numbers in that section. So looking at fiscal year 2025, the guidance reflects, number one, lower earnings, which fall to cash flow. Also, a portion of those other working capital benefits that helped fiscal year 2024 are forecasted to reverse. And then that's partially offset by a lower estimated CapEx in 2025 versus 2024. So all that said, the free cash flow to net income ratio, which I cited in my prepared remarks, for fiscal year 2025, the guidance comes in between 1.2 and 1.3 times. That's free cash flow to net income. So broadly in line with our expectations. Great. This has all been very helpful. Thank you very much for answering my questions. You bet. Okay. Operator, back to you. Thank you, ladies and gentlemen. This does conclude today's Q&A conference and today's event. We would like to thank you for your participation in Maximus's call today. You may disconnect your lines or log off the webcast and enjoy the rest of your day.